Novo Nordisk's Wegovy: A Game Changer in Obesity Treatment
Novo Nordisk has launched Wegovy, the first oral GLP-1 pill for weight loss in the U.S., offering a more accessible treatment option for those battling obesity—a significant step forward in the fight against an epidemic affecting millions.
Read full article




























